Annual EBIT
-$279.00M$20.00M+6.69%
Summary
- Current Value
- As of today, RCUS annual EBIT is -$279.00M, up +6.69% on
- Historical Performance
- RCUS annual EBIT is down -607.27% over the past 3 years, and down -229.36% over the past 5 years
- All-Time High Comparison
- RCUS annual EBIT is currently -607.27% below its historical high of $55.00M set on
- 3-Year Low Comparison
- RCUS annual EBIT is +6.69% above its 3-year low of -$299.00M reached on
- Sector Comparison
- RCUS annual EBIT is higher than 5.25% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$279.00M | +6.7% | -607.3% | -229.4% | -1434.5% | |
| Quarterly EBIT | -$142.00M | -35.2% | -104.6% | -9249.5% | -1845.2% | |
| TTM EBIT | -$375.00M | -25.8% | -595.3% | -317.8% | -5037.0% | |
| Price | $21.14 | +41.7% | +20.7% | -31.4% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $258.00M | +120.5% | -32.6% | +1620.0% | +100.0% | |
| Annual EPS | -$3.14 | +24.3% | -539.8% | -62.5% | -664.8% | |
| Annual EBITDA | -$269.00M | +7.6% | -555.9% | -231.6% | -1494.7% | |
| Annual Net Income | -$283.00M | +7.8% | -635.7% | -234.1% | -1474.8% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$264.00M | N/A | -5.7% |
| 5Y | $55.00M | -607.3% | |
| All | $55.00M | -607.3% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$299.00M | +6.7% | |
| 5Y | -$299.00M | +6.7% | |
| All | -$299.00M | +6.7% |
EBIT History
| Year | Value | Change |
|---|---|---|
| -$279.00M | +6.7% | |
| -$299.00M | -13.3% | |
| -$264.00M | -580.0% | |
| $55.00M | +144.7% | |
| -$123.00M | -45.2% |
| Year | Value | Change |
|---|---|---|
| -$84.71M | -54.4% | |
| -$54.86M | -2.7% | |
| -$53.44M | -193.9% | |
| -$18.18M | - |
FAQ
What is the current annual EBIT of RCUS?
As of today, RCUS annual EBIT is -$279.00M
What is 1-year change in RCUS annual EBIT?
RCUS annual EBIT is up +6.69% year-over-year
What is 3-year change in RCUS annual EBIT?
RCUS annual EBIT is down -607.27% over the past 3 years
How far is RCUS annual EBIT from its all-time high?
RCUS annual EBIT is currently -607.27% below its historical high of $55.00M set on December 31, 2021
How does RCUS annual EBIT rank versus sector peers?
RCUS annual EBIT is higher than 5.25% of companies in Healthcare sector
When is RCUS next annual earnings release?
The next annual earnings release for RCUS is on
Quarterly EBIT
-$142.00M$134.00M-1,675.00%
Summary
- Current Value
- As of today, RCUS quarterly EBIT is -$142.00M, down -1675.00% on
- Historical Performance
- RCUS quarterly EBIT is down -35.24% year-over-year, and down -104.62% over the past 3 years
- All-Time High Comparison
- RCUS quarterly EBIT is currently -150.49% below its historical high of $281.27M set on
- 3-Year Low Comparison
- RCUS quarterly EBIT is at its 3-year low
- Sector Comparison
- RCUS quarterly EBIT is higher than 1.61% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | -$142.00M | -1675.0% | -35.2% | -104.6% | -9249.5% | |
| Annual EBIT | -$279.00M | – | +6.7% | -607.3% | -229.4% | |
| TTM EBIT | -$375.00M | -10.9% | -25.8% | -595.3% | -317.8% | |
| Price | $21.14 | +39.5% | +41.7% | +20.7% | -31.4% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $26.00M | -83.8% | -45.8% | -22.6% | -59.7% | |
| Quarterly EPS | -$1.27 | -100.0% | -25.9% | -41.0% | -4627.1% | |
| Quarterly EBITDA | -$140.00M | -2233.3% | -35.9% | -112.8% | -4224.9% | |
| Quarterly Net Income | -$135.00M | -100.0% | -46.7% | -108.0% | -7509.4% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$8.00M | -1675.0% | |
| 3Y | $4.00M | -3650.0% | |
| 5Y | $281.27M | -150.5% | |
| All | $281.27M | -150.5% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$142.00M | at low | |
| 3Y | -$142.00M | at low | |
| 5Y | -$142.00M | at low | |
| All | -$142.00M | at low |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of RCUS?
As of today, RCUS quarterly EBIT is -$142.00M
What is RCUS quarterly EBIT most recent change?
RCUS quarterly EBIT was down -1675.00% on September 30, 2025
What is 1-year change in RCUS quarterly EBIT?
RCUS quarterly EBIT is down -35.24% year-over-year
How far is RCUS quarterly EBIT from its all-time high?
RCUS quarterly EBIT is currently -150.49% below its historical high of $281.27M set on December 31, 2021
How does RCUS quarterly EBIT rank versus sector peers?
RCUS quarterly EBIT is higher than 1.61% of companies in Healthcare sector
When is RCUS next earnings release?
The next earnings release for RCUS is on
TTM EBIT
-$375.00M$37.00M-10.95%
Summary
- Current Value
- As of today, RCUS TTM EBIT is -$375.00M, down -10.95% on
- Historical Performance
- RCUS TTM EBIT is down -25.84% year-over-year, and down -595.32% over the past 3 years
- All-Time High Comparison
- RCUS TTM EBIT is currently -595.32% below its historical high of $75.71M set on
- 3-Year Low Comparison
- RCUS TTM EBIT is +13.99% above its 3-year low of -$436.00M reached on
- Sector Comparison
- RCUS TTM EBIT is higher than 3.03% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | -$375.00M | -10.9% | -25.8% | -595.3% | -317.8% | |
| Annual EBIT | -$279.00M | – | +6.7% | -607.3% | -229.4% | |
| Quarterly EBIT | -$142.00M | -1675.0% | -35.2% | -104.6% | -9249.5% | |
| Price | $21.14 | +39.5% | +41.7% | +20.7% | -31.4% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $240.00M | -8.4% | -8.8% | -44.5% | +208.6% | |
| TTM EPS | -$3.43 | -8.2% | -8.8% | -470.6% | -80.2% | |
| TTM EBITDA | -$365.00M | -11.3% | -27.6% | -511.3% | -327.3% | |
| TTM Net Income | -$341.00M | -14.4% | -26.3% | -527.2% | -289.3% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$310.00M | N/A | -21.0% |
| 3Y | -$250.00M | -50.0% | |
| 5Y | $75.71M | -595.3% | |
| All | $75.71M | -595.3% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$436.00M | +14.0% | |
| 3Y | -$436.00M | +14.0% | |
| 5Y | -$436.00M | +14.0% | |
| All | -$436.00M | +14.0% |
TTM EBIT History
FAQ
What is the current TTM EBIT of RCUS?
As of today, RCUS TTM EBIT is -$375.00M
What is RCUS TTM EBIT most recent change?
RCUS TTM EBIT was down -10.95% on September 30, 2025
What is 1-year change in RCUS TTM EBIT?
RCUS TTM EBIT is down -25.84% year-over-year
How far is RCUS TTM EBIT from its all-time high?
RCUS TTM EBIT is currently -595.32% below its historical high of $75.71M set on September 30, 2022
How does RCUS TTM EBIT rank versus sector peers?
RCUS TTM EBIT is higher than 3.03% of companies in Healthcare sector
When is RCUS next earnings release?
The next earnings release for RCUS is on
EBIT Formula
EBIT = − −
Data Sources & References
- RCUS Official Website www.arcusbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1724521/000172452125000116/0001724521-25-000116-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1724521/000172452125000040/0001724521-25-000040-index.htm
- RCUS Profile on Yahoo Finance finance.yahoo.com/quote/RCUS
- RCUS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rcus